Clinical Trials Browser

Phase 2 × Suspended × Imatinib Mesylate × Clear all

NCT01222013 2013-03-26

Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)

Phase 2 Suspended

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma